Kamada Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · Israel

Last price 7.95 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 451.69M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f...